2,588 results on '"van der Heijde, D."'
Search Results
2. POS0026 PATIENT AND DISEASE CHARACTERISTICS ASSOCIATED WITH GLOBAL FUNCTIONING AND HEALTH (ASAS HI) IN AXIAL SPONDYLOARTHRITIS: A MIXED-EFFECTS MODEL ANALYSIS OF LONGITUDINAL DATA FROM THE DESIR COHORT
3. POS0011 FACTORS ASSOCIATED WITH THE EVOLUTION OF DEGENERATIVE SPINAL LESIONS IN AXIAL SPONDYLOARTHRITIS: 10-YEAR FOLLOW-UP OF THE DESIR COHORT
4. OP0021 3-YEAR RESULTS OF TAPERING TNFi TO WITHDRAWAL COMPARED TO STABLE TNFi AMONG RHEUMATOID ARTHRITIS PATIENTS IN SUSTAINED REMISSION: A MULTICENTER RANDOMIZED TRIAL
5. POS0005 A TWO-YEAR COMPARISON OF BACK PAIN AND MORNING STIFFNESS BETWEEN AXIAL SPONDYLOARTHRITIS AND CHRONIC BACK PAIN PATIENTS IN THE SPONDYLOARTHRITIS CAUGHT EARLY (SPACE) COHORT
6. OP0223 CLINICAL AND IMAGING OUTCOMES OF DIFFERENT PHENOTYPES OF AXIAL SPONDYLOARTHRITIS: 5-YEAR ANALYSIS OF THE DESIR COHORT
7. POS0503 PREDICTIVE VALIDITY OF DATA-DRIVEN DEFINITIONS FOR ACTIVE AND STRUCTURAL LESIONS IN THE SI JOINTS TYPICAL FOR AXIAL SPA: A 2-YEAR FOLLOW-UP IN THE SPONDYLOARTHRITIS CAUGHT EARLY COHORT
8. POS0222 ASDAS RESPONSES IN PATIENTS WITH AXIAL SPONDYLOARTHRITIS STARTING BDMARDS: RESULTS FROM A MULTICENTRE PROSPECTIVE COHORT
9. POS0806 LONG-TERM SUSTAINED EFFICACY AND SAFETY OF BIMEKIZUMAB ACROSS THE FULL SPECTRUM OF AXIAL SPONDYLOARTHRITIS: 2-YEAR RESULTS FROM TWO PHASE 3 STUDIES
10. POS0050 EFFICACY AND SAFETY OF UPADACITINIB IN PATIENTS WITH ACTIVE NON-RADIOGRAPHIC AXIAL SPONDYLOARTHRITIS: 2-YEAR DATA FROM THE PHASE 3 SELECT-AXIS 2 STUDY
11. POS0506 THE LONGITUDINAL ASSOCIATION BETWEEN DISEASE ACTIVITY, FUNCTION AND HEALTH-RELATED QUALITY OF LIFE IN AXIAL SPONDYLOARTHRITIS: RESULTS FROM THE DESIR COHORT
12. POS0510 A TWO-YEAR COMPARISON OF SPINAL AND HIP MOBILITY BETWEEN AXIAL SPONDYLOARTHRITIS AND CHRONIC BACK PAIN PATIENTS IN THE SPONDYLOARTHRITIS CAUGHT EARLY (SPACE) COHORT
13. OP0310 HOW EARLY IS EARLY? UNVEILING TIME TO DIAGNOSIS SINCE SYMPTOM ONSET AND ITS DETERMINANTS IN PATIENTS SUSPECTED OF EARLY AXIAL SPONDYLOARTHRITIS: DATA FROM THE SPONDYLOARTHRITIS CAUGHT EARLY (SPACE) COHORT
14. OP0303 CLEAR DIFFERENCES IN STRUCTURAL MRI LESIONS BETWEEN AXIAL SPONDYLOARTHRITIS PATIENTS AND PATIENTS WITH CHRONIC BACK PAIN, WOMEN WITH POSTPARTUM BACK PAIN, RUNNERS AND HEALTHY SUBJECTS
15. POS1381 NATURAL COURSE OF DEGENERATIVE CHANGES OF THE SPINE ON RADIOGRAPHS AND MRI IN AXIAL SPONDYLOARTHRITIS FOLLOWED 10 YEARS IN THE DESIR COHORT
16. POS0215 LONG-TERM SAFETY AND EFFICACY OF BIMEKIZUMAB IN PATIENTS WITH ACTIVE ANKYLOSING SPONDYLITIS: 5-YEAR RESULTS FROM A PHASE 2B STUDY AND ITS OPEN-LABEL EXTENSION
17. POS0798 EFFICACY, SAFETY AND RADIOGRAPHIC OUTCOMES FROM THE PHASE 3 SELECT-AXIS 2 STUDY OF UPADACITINIB IN PATIENTS WITH ACTIVE ANKYLOSING SPONDYLITIS AND AN INADEQUATE RESPONSE TO BIOLOGIC DMARD THERAPY: 2-YEAR DATA
18. The ASAS-OMERACT core domain set for axial spondyloarthritis
19. Le bimékizumab permet le maintien des réponses cliniques évaluées par des critères stricts jusqu’à la semaine 52 chez les patients atteints de spondyloarthrite axiale : résultats des études de phase III BE MOBILE 1 et BE MOBILE 2
20. Tolérance et efficacité à long terme du bimékizumab chez les patients atteints de spondylarthrite ankylosante active : résultats à 5 ans d’une étude de phase IIb et de son extension en ouvert
21. Effet du sécukinumab versus adalimumab biosimilaire sur la progression radiographique chez les patients atteints de spondyloarthrite axiale radiographique : analyse en sous-groupes avec sur le statut syndesmophytes et protéine C-réactive à l’inclusion
22. Effet du sécukinumab versus adalimumab biosimilaire sur la progression radiographique chez les patients atteints de spondyloarthrite axiale radiographique : étude randomisée de phase 3b
23. Performance of the Michigan Hand Outcomes Questionnaire in hand osteoarthritis
24. POS0671 VALIDATION OF TWO RESPONSE AND ONE STATUS MEASURES OF THE ASAS HEALTH INDEX VERSUS EXTERNAL ANCHORS IN PATIENTS WITH AXIAL SPONDYLOARTHRITIS
25. POS1122 EFFICACY AND SAFETY OF UPADACITINIB IN PATIENTS WITH ACTIVE ANKYLOSING SPONDYLITIS AND AN INADEQUATE RESPONSE TO BIOLOGIC DMARD THERAPY: ONE-YEAR RESULTS FROM A PHASE 3 STUDY
26. POS0660 FACET JOINT INFLAMMATION IS RARE, BUT WHEN PRESENT IT IS ASSOCIATED WITH FACET JOINT ANKYLOSIS IN RADIOGRAPHIC AXIAL SPONDYLOARTHRITIS PATIENTS FROM THE SIAS COHORT
27. POS1118 DISCRIMINATING CAPACITY OF THE ASAS HEALTH INDEX IN PATIENTS TREATED WITH IXEKIZUMAB IN THE COAST PROGRAMME
28. POS0181 THE IMPACT OF AUTOANTIBODIES (RF AND ACPA) ON THE EFFICACY OF BIOLOGICAL DISEASE-MODIFYING ANTIRHEUMATIC DRUGS IN RHEUMATOID ARTHRITIS: META-ANALYSIS OF RANDOMIZED CONTROLLED TRIALS
29. POS1104 BIMEKIZUMAB MAINTAINED STRINGENT CLINICAL RESPONSES THROUGH WEEK 52 IN PATIENTS WITH AXIAL SPONDYLOARTHRITIS: RESULTS FROM THE PHASE 3 STUDIES BE MOBILE 1 AND BE MOBILE 2
30. OP0005 CAN AXIAL SPONDYLOARTHRITIS UNEQUIVOCALLY BE DIAGNOSED BY RHEUMATOLOGISTS IN PATIENTS WITH CHRONIC BACK PAIN OF LESS THAN TWO YEARS DURATION? MAIN RESULT OF THE SPONDYLOARTHRITIS CAUGHT EARLY (SPACE) COHORT
31. AB0977 CHANGES IN ASDAS AND SYMPTOMS OF ANXIETY AND DEPRESSION IN AXIAL SPONDYLOARTHRITIS: LATENT TRAJECTORY ANALYSIS
32. OP0189 REMISSION CRITERIA GUIDING IMMUNOSUPPRESSIVE THERAPY IN RA: WHICH IS BEST FITTED FOR THIS PURPOSE?
33. POS0250 PLACEBO-CONTROLLED EFFICACY AND SAFETY OF UPADACITINIB THROUGH ONE YEAR IN PATIENTS WITH NON-RADIOGRAPHIC AXIAL SPONDYLOARTHRITIS
34. OP0059 EFFECT OF SECUKINUMAB VERSUS ADALIMUMAB BIOSIMILAR ON RADIOGRAPHIC PROGRESSION IN PATIENTS WITH RADIOGRAPHIC AXIAL SPONDYLOARTHRITIS: A RANDOMISED PHASE IIIB STUDY
35. POS0688 COMPARING THE CONSTRUCT VALIDITY AMONG MEASURES OF PAIN AND STIFFNESS IN PATIENTS WITH AXIAL SPONDYLOARTHRITIS
36. OP0055 ASAS CONSENSUS DEFINITION OF EARLY AXIAL SPONDYLOARTHRITIS
37. POS0244 PROTOCOL VIOLATION IN A TREAT-TO-TARGET STRATEGY IN AXIAL SPONDYLOARTHRITIS: DATA FROM THE OPEN-LABEL, PRAGMATIC, CLUSTER-RANDOMISED TICOSPA TRIAL
38. POS0678 PERFORMANCE OF CLINICAL, LABORATORY AND IMAGING FEATURES FOR THE DIAGNOSIS OF AXIAL SPONDYLOARTHRITIS - A SYSTEMATIC LITERATURE REVIEW AND META-ANALYSIS
39. POS0049 CLINICAL AND RADIOGRAPHIC RESULTS OF TAPERING AND WITHDRAWING CSDMARDS VERSUS STABLE TREATMENT IN RHEUMATOID ARTHRITIS REMISSION: 3-YEAR RESULTS FROM A RANDOMIZED CONTROLLED TRIAL
40. OP0054 THE YIELD OF REPEATED ASSESSMENTS IN CHRONIC BACK PAIN PATIENTS SUSPECTED OF EARLY AXIAL SPONDYLOARTHRITIS: TWO-YEAR DATA FROM THE SPONDYLOARTHRITIS CAUGHT EARLY (SPACE) COHORT
41. POS1103 BIMEKIZUMAB MAINTAINED IMPROVEMENTS IN EFFICACY ENDPOINTS AND HAD A CONSISTENT SAFETY PROFILE THROUGH 52 WEEKS IN PATIENTS WITH NON-RADIOGRAPHIC AND RADIOGRAPHIC AXIAL SPONDYLOARTHRITIS: RESULTS FROM TWO PARALLEL PHASE 3 STUDIES
42. Synovitis and radiographic progression in non-erosive and erosive hand osteoarthritis: is erosive hand osteoarthritis a separate inflammatory phenotype?
43. Two-year imaging outcomes from a phase 3 randomized trial of secukinumab in patients with non-radiographic axial spondyloarthritis
44. Spinal radiographic progression over 2 years in ankylosing spondylitis patients treated with secukinumab: a historical cohort comparison
45. Medicamentos antinflamatorios no esteroideos para casos agudos de gota
46. Prevalence and clinical significance of lumbosacral transitional vertebra (LSTV) in a young back pain population with suspected axial spondyloarthritis: results of the SPondyloArthritis Caught Early (SPACE) cohort
47. Illness Perceptions and Outcomes in Patients with Inflammatory Bowel Disease: Is Coping a Mediator?
48. EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2022 update
49. Amélioration des signes et symptômes chez des patients atteints de spondyloarthrite axiale radiographique traités par bimékizumab : résultats à 24 semaines d’une étude de phase III, multicentrique, randomisée et contrôlée par placebo
50. Efficacité et tolérance d’upadacitinib chez des patients atteints de spondylarthrite ankylosante et ayant eu une intolérance et/ou un manque d’efficacité lors d’un traitement antérieur par biologique : analyse en sous-groupes
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.